ClinicalTrials.Veeva

Menu

Open Label Trial of Utility of Cryobiopsy in the Multidisciplinary Diagnosis of Idiopathic Interstitial Lung Disease

U

University Hospital Tuebingen

Status

Unknown

Conditions

Interstitial Lung Disease

Treatments

Procedure: Lung biopsy

Study type

Interventional

Funder types

Other

Identifiers

NCT02563730
CRYO-VATS

Details and patient eligibility

About

A multicenter, multinational, prospective study to clarify, whether the addition of cryobiopsy can avoid surgical lung biopsy in a clinically relevant proportion of patients with suspected Idiopathic Interstitial Pneumonia

Enrollment

100 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • IIP suspected on clinical and radiologic grounds

Exclusion criteria

  • Age >80y and <18y
  • FVC< 55%, DCO<35%
  • Platelet count <100000/µl
  • acetylsalicylic acid, clopidogrel or equivalent during the last 5 days
  • INR > l,3,
  • elevated PTT (> 40 s)
  • documented pulmonary hypertension PAPS >50mmHg
  • HR-CT highly suspicious for sarcoidosis

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 1 patient group

Lung biopsy
Experimental group
Description:
assess the additional diagnostic value of cryobiopsy in patients with suspected Idiopathic Interstitial Pneumonia (IIP). Cryoprobe vs VATS
Treatment:
Procedure: Lung biopsy

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems